CSI Market
Sign In | Register

Reviva Pharmaceuticals Holdings Inc (RVPH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RVPH Annual Balance Sheets →
The data below summarizes Reviva Pharmaceuticals Holdings Inc's balance sheet position from Jun 30 2025 to Sep 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RVPH/balance-sheets
https://api.csimarket.com/api/v1/companies/RVPH/fundamentals
https://api.csimarket.com/api/v1/companies/RVPH/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent17.46
Cash, Cash Equivalents Other16.19
Cash & Short-term Investments33.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.28
Total Current Assets18.56
Other Assets, Noncurrent0.00
Prepaid Clinical Trial Costs0.82
Prepaid Clinical Trial Costs Noncurrent-
Total Assets18.56
Liabilities
Accounts Payable, Current AC2.48
Employee-related Liabilities, Current AC0.65
Short-term Debt DE10.04
Other Liabilities, Current2.30
Total Current Liabilities5.48
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent0.00
Accrued Clinical Expenses2.68
Total Liabilities5.48
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock205.15
Retained Earnings / Accumulated Deficit-192.08
Other Equity0.00
Common Stockholder's Equity13.08
Total Stockholder's Equity13.08
Liabilities & Stockholder's Equity18.56
4 historic quarters locked

Sign in to unlock the full Reviva Pharmaceuticals Holdings Inc balance sheet history.

Sign In Create Free Account

About Reviva Pharmaceuticals Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-036648

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI